# Safety and Tolerability of Sodium Thiosulfate in Patients With an ACS Undergoing CAG Via Trans-radial Approach.

> **NCT03017963** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 18 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Sodium Thiosulfate Pentahydrate

## Key facts

- **NCT ID:** NCT03017963
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-06
- **Primary completion:** 2018-03-23
- **Final completion:** 2018-03-23
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2018-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03017963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03017963, "Safety and Tolerability of Sodium Thiosulfate in Patients With an ACS Undergoing CAG Via Trans-radial Approach.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03017963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*